JP4464646B2 - Misuse prevention label - Google Patents
Misuse prevention label Download PDFInfo
- Publication number
- JP4464646B2 JP4464646B2 JP2003321901A JP2003321901A JP4464646B2 JP 4464646 B2 JP4464646 B2 JP 4464646B2 JP 2003321901 A JP2003321901 A JP 2003321901A JP 2003321901 A JP2003321901 A JP 2003321901A JP 4464646 B2 JP4464646 B2 JP 4464646B2
- Authority
- JP
- Japan
- Prior art keywords
- layer
- label
- masking agent
- main body
- information transmission
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000002265 prevention Effects 0.000 title claims description 5
- 239000010410 layer Substances 0.000 claims description 36
- 239000000853 adhesive Substances 0.000 claims description 28
- 230000001070 adhesive effect Effects 0.000 claims description 27
- 230000005540 biological transmission Effects 0.000 claims description 24
- 239000003795 chemical substances by application Substances 0.000 claims description 23
- 230000000873 masking effect Effects 0.000 claims description 22
- 239000002344 surface layer Substances 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 8
- 238000000926 separation method Methods 0.000 claims description 7
- 239000011241 protective layer Substances 0.000 claims description 6
- 229920003002 synthetic resin Polymers 0.000 claims description 3
- 239000000057 synthetic resin Substances 0.000 claims description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 2
- 229910052782 aluminium Inorganic materials 0.000 claims description 2
- 238000007740 vapor deposition Methods 0.000 claims 2
- 239000011888 foil Substances 0.000 claims 1
- 239000012790 adhesive layer Substances 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 239000000123 paper Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 239000003708 ampul Substances 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000004925 Acrylic resin Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 239000003999 initiator Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- UHESRSKEBRADOO-UHFFFAOYSA-N ethyl carbamate;prop-2-enoic acid Chemical compound OC(=O)C=C.CCOC(N)=O UHESRSKEBRADOO-UHFFFAOYSA-N 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 239000011086 glassine Substances 0.000 description 1
- 239000012943 hotmelt Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- KCTAWXVAICEBSD-UHFFFAOYSA-N prop-2-enoyloxy prop-2-eneperoxoate Chemical compound C=CC(=O)OOOC(=O)C=C KCTAWXVAICEBSD-UHFFFAOYSA-N 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Landscapes
- Details Of Rigid Or Semi-Rigid Containers (AREA)
Description
本発明は、医薬用容器と機器に使用するラベルに関する。 The present invention relates to labels for use in pharmaceutical containers and equipment.
医療用薬品を充填した容器は見え易い場所に商品名・成分・用法・容量・製造ロット・有効期限等を明記したラベルを貼付けている。ラベルは貼付け後に剥離可能なタイプと剥離し難いタイプとがあり、何れも容器内容物が消費される迄の期間、容器から剥離されずに使用する。然し、医療現場で使用する注射器のような器具にはラベル表示はなく、使用に当たり医師や看護士等がカルテと容器のラベルを確認し、注射器に薬液を移し換えて使用する。 Containers filled with medical chemicals are affixed with labels that clearly indicate the product name, ingredients, usage, capacity, production lot, expiration date, etc. There are two types of labels: a type that can be peeled off after sticking and a type that is difficult to peel off. Both of them are used without being peeled from the container until the container contents are consumed. However, there is no label display on a device such as a syringe used in a medical field, and in use, a doctor, a nurse or the like confirms the label of the medical record and the container, and transfers the drug solution to the syringe for use.
医薬品に使用するラベルは基材が紙や合成紙樹脂フィルム等で、一方に印刷面、他方に接着面を設けた3層タイプを使用することが多い。特徴のあるラベルには結露対策を備えるものもある。例えば、血液パック用はラベルの内部が紙基材・ホットメルト層・クレーコート層・撥水層・印刷層の5層構造になっている(下記特許文献1参照)。
容器から薬液を注射器のような器具に移替えて使用する場合、患者に処置する前に確認すべきことが多い。例えば、容器内の薬液が医師の指示通りか、有効期限はないか、注射器に移した薬液量に間違いはないか、一度手から離した注射器を取り違えていないか等がある。従って、通常のラベルや血液パック用のラベル等は、多項目の確認作業を伴う用途には適さない。また、用済み容器の廃棄する際には表示ラベルが剥がし難い。本発明は、上記問題を解決した誤用防止ラベルの提供を目的とする。 When a drug solution is transferred from a container to a device such as a syringe, it is often to be confirmed before treating the patient. For example, whether the medicine in the container is as instructed by the doctor, there is no expiration date, there is no mistake in the amount of medicine transferred to the syringe, or the syringe once removed from the hand is mistaken. Therefore, a normal label, a label for a blood pack, and the like are not suitable for an application involving confirmation work for many items. In addition, the display label is difficult to peel off when the used container is discarded. An object of the present invention is to provide a misuse prevention label that solves the above problems.
本発明は、基材である表層(4)を有する所要のサイズのラベル(1)を、本体部(13)と情報伝達部(17)に分かち、前記本体部(13)と前記情報伝達部(17)の間に、引き裂き用ミシン目(12)を設け、前記表層(4)表面には、印刷を施した画線層(3)と、記名部(18)・捺印部(15)を除く前記画線層(3)上に不粘着性マスキング剤を塗布した保護層(2)を設け、前記表層(4)の背面には、粘着剤層(5)と、不粘着性マスキング剤を塗布した調整層(6)と、剥離セパレート層(7)とをその順に設け、前記本体部(13)表面の不粘着性マスキング剤は厚み2〜2.5μmで網点がなく、前記本体部(13)背面の不粘着性マスキング剤は厚み1〜1.5μmで、範囲20〜50%から選択した網点として塗布し、前記情報伝達部(17)表面の不粘着性マスキング剤は厚み2〜2.5μmで網点がなく、前記情報伝達部(17)の背面不粘着性マスキング剤は厚み1〜1.5μmで、網点なし又は範囲10〜30%から選択した網点を塗布したことを特徴とする誤用防止ラベルである。 The present invention divides a label (1) of a required size having a surface layer (4) as a base material into a main body (13) and an information transmission section (17), and the main body (13) and the information transmission section. A tear perforation (12) is provided between (17), and the surface layer (4) has a printed image line layer (3), a name part (18) and a stamp part (15) on the surface. the streaked layer (3) protective layer coated tack masking agent on (2) is provided, except on the back surface of said surface layer (4), viscosity Chakuzaiso and (5), tack masking agent An adjustment layer (6) coated with a release layer and a separation layer (7) are provided in that order, and the non-adhesive masking agent on the surface of the main body (13) has a thickness of 2 to 2.5 μm and has no halftone dots, and the main body. Part (13) The non-adhesive masking agent on the back has a thickness of 1 to 1.5 μm and is a halftone dot selected from the range 20 to 50%. The non-adhesive masking agent on the surface of the information transmission part (17) has a thickness of 2 to 2.5 μm and no halftone dots, and the back non-adhesive masking agent of the information transmission part (17) has a thickness of 1-1. A misuse prevention label characterized by being coated with a halftone dot selected from the range of 10 to 30% without a halftone dot at 5 μm.
医療従事者が患者を診断した後、注射等の処置を施す場合、誤用防止ラベルの情報伝達部の記名部を利用して、患者名や薬液量等必要な事項を記入する。情報伝達部を本体部ラベルから切り離して記入し、医療機器(例えば注射器)に情報伝達部を貼付けると医療機具の使用目的が他の医療従事者にも正しく伝わるので誤用防止に役立つ。 When a medical worker diagnoses a patient and performs a procedure such as injection, the necessary information such as the patient name and the amount of medicinal solution is entered by using the name portion of the information transmission part of the misuse prevention label. If the information transmission part is written separately from the main body part label and the information transmission part is affixed to a medical device (for example, a syringe), the purpose of use of the medical device is correctly transmitted to other medical personnel, which helps prevent misuse.
処置終了後に医療機具の確認ラベルを剥がして、カルテに貼付けるとカルテへの記入作業の省略並びにカルテ記載時の薬名の誤記等が防止できる。また、用済みのバイアル・アンプル等に貼付けた本体ラベルは粘着力を弱くしてあるので剥がし易く、医療機具に貼付けた用済みの情報伝達部ラベルは粘着面積が少なく再剥離し易いので、廃棄時の分別処理がし易くなる。 When the medical device confirmation label is peeled off and pasted on the medical chart after the treatment is completed, it is possible to prevent omission of the entry work on the medical chart and incorrect writing of the drug name when writing the medical chart. In addition, the main body label attached to used vials / ampoules etc. has weak adhesive strength, so it is easy to peel off, and the used information transmission part label attached to medical equipment has a small adhesive area and is easy to peel off again. This makes it easier to separate time.
本発明は、蒸着膜の有無に関わりなく、紙・アルミニウム泊・合成樹脂フィルムから選択したシートを表層(基材)にして、該表層両面に積層して五〜六層構造としたラベルである。所要サイズのラベルの所要位置に引き裂き用のミシン目を設け、該ミシン目を境にした一方の本体部をバイアルやアンプル等の容器側で使用し、他方の情報伝達部を容器内の薬液を移す注射器等の側で使用し、両部の表示内容から誤用を防止するラベルである。表層裏面の粘着層に続く剥離セパレート層は紙・グラシン・フィルム等から選択する。 The present invention is a label having a five- to six-layer structure in which a sheet selected from paper, aluminum stays, and a synthetic resin film is used as a surface layer (base material) regardless of the presence or absence of a deposited film, and is laminated on both surfaces of the surface layer. . A perforation for tearing is provided at a required position of a label of a required size, and one main body part with the perforation as a boundary is used on the side of a container such as a vial or ampoule, and the other information transmission part is used for a chemical solution in the container. It is a label that is used on the side of the syringe to be transferred and prevents misuse from the display contents of both parts. The separation layer that follows the adhesive layer on the back of the surface layer is selected from paper, glassine, film, and the like.
本体部に望まれる要件は、裏面の粘着部の粘着力が容器に貼付け後も剥離し易く、表面に所要の画線層(印刷)と容器充填物を確認する捺印部を備えることである。また、情報伝達部を含め表・裏に塗布する不粘着性マスキング剤は使用目的を勘案して、同剤を転写するための網目サイズを決める。捺印部以外の表面はマスキング剤を厚み2〜2.5μmの範囲で網目なく塗布する。裏面にはマスキング剤の厚み1〜1.5μmの範囲に塗布し、20〜50%の範囲から選択した網点で粘着層を覆い粘着力を調整して区分する。 The requirement for the main body part is that the adhesive force of the adhesive part on the back surface is easily peeled off even after being applied to the container, and a stamping part for confirming a required image layer (printing) and container filling is provided on the surface. In addition, the non-adhesive masking agent applied to the front and back, including the information transmission part , determines the mesh size for transferring the agent in consideration of the purpose of use. Surfaces other than the seal portion is a mesh without applying a masking agent in a range of thickness 2~2.5μ m. The back surface is applied to a range of thickness 1~1.5Myu m masking agent, dividing by adjusting the adhesive strength covering the adhesive layer on the selected dot from the range of 20-50%.
情報伝達部に望まれる要件は、容器に貼付けた本体部から切り離し易く、切り離し後に粘着部の粘着力が再使用に耐えることである。裏面は本体部から続く粘着部にマスキング剤を厚み1〜1.5μmの範囲で塗布し、10〜30%の範囲から選択した網点並びに網目なしで粘着層を覆い粘着力を調整して区分する。表面は患者名や薬液量等を記入する記名部を除き、本体部と同じ条件でマスキング剤を続けて塗布する。 The requirement desired for the information transmission part is that it can be easily separated from the main body part affixed to the container, and the adhesive force of the adhesive part can withstand reuse after the separation. The back side is divided by applying a masking agent in the range of 1 to 1.5 μm in thickness to the adhesive part that continues from the main body part, covering the adhesive layer without a halftone dot and mesh selected from the range of 10 to 30%, and adjusting the adhesive strength To do. The masking agent is continuously applied to the surface under the same conditions as the main body, except for the name area where the patient name and the amount of the drug solution are entered.
不粘着性マスキング剤は用途に合わせ必要箇所の必要面積に塗布し、微細な形状の網点を形成するために、タルク・炭酸カリウム・エポキシアクリレート樹脂・ウレタンアクリレート樹脂・2官能アクリレートモノマー・多官能アクリレートモノマー・自己解裂型光重合開始剤・ポリエチレンワックス・安定剤・界面活性剤等から選択して、所要の組成を構成する。マスキング剤で粘着層の粘着力をゼロ(網目未使用)から最大(未塗布)の間で自由に調整できる。 Non-adhesive masking agent is applied to the required area of the required location according to the application, and talc, potassium carbonate, epoxy acrylate resin, urethane acrylate resin, bifunctional acrylate monomer, multifunctional to form a finely shaped halftone dot The composition is selected from acrylate monomers, self-cleaving photopolymerization initiators, polyethylene waxes, stabilizers, surfactants, and the like. The adhesive strength of the adhesive layer can be freely adjusted with a masking agent between zero (unused mesh) and maximum (uncoated).
本体部と情報伝達部の面積比は、本体部と情報伝達部の数が1対1の時、ラベル面積に対する本体部面積を50〜80%の範囲から選択するが、情報伝達部の数が複数化した時はラベルが特定方向に長くなるので前記範囲を超えて設定し、残りの面積を情報伝達部に当てればよい。通常、ラベルの貼付け方向はバイアル等の容器の胴に捲いて使用する。 The area ratio of the main body portion and the information transmitting unit, when the number of the body portion and the information transmitting unit is 1: 1, but selecting the main body area to label the area from the range of 50-80%, the number of information transmission unit When a plurality of labels are used, the label becomes longer in a specific direction. Therefore, the label may be set beyond the range, and the remaining area may be applied to the information transmission unit . Usually, the label is attached to the body of a container such as a vial.
図1はラベル表面図、図2はラベル裏面図、図3,4は図1のa−aとb−b線に沿う六層と五層構造のラベル断面図で、使用前の状態に相当する。図3の保護層2(不粘着性マスキング層)・画線層3(印刷層)・表層4(基材)・粘着層5・調整層6(不粘着性マスキング層)・剥離セパレート層7からなる積層体で、図4には保護層がない。使用時には剥離セパレート層7は除去される。 1 is a front view of the label, FIG. 2 is a rear view of the label, and FIGS. 3 and 4 are cross-sectional views of the six-layer and five-layer structures along the lines aa and bb in FIG. To do. From the protective layer 2 (non-adhesive masking layer), the image layer 3 (printing layer), the surface layer 4 (base material), the adhesive layer 5, the adjustment layer 6 (non-adhesive masking layer), and the release separate layer 7 in FIG. In FIG. 4, there is no protective layer. In use, the separation layer 7 is removed.
紙を表層(基材)に使用したラベル1は、分離用の切欠き11,11とミシン目12を境にして、全体面積の2/3の本体部13と残り1/3の情報伝達部17に分かれる。本体部は容器に貼るラベルで、情報伝達部は本体部と共に一旦容器に貼付けた後、剥がして注射器等の医療器具に貼り替えるラベルで、容器内の薬液を移替えた後も使用目的が確実に伝わるための情報伝達手段として使用する。 The label 1 using paper as the surface layer (base material) has a main body 13 of 2/3 of the total area and the remaining 1/3 of the information transmission section with the notches 11 and 11 for separation and the perforation 12 as a boundary. Divided into 17. The main body is a label that is affixed to the container, and the information transmission part is a label that is once affixed to the container together with the main body, and then peeled off and replaced with a medical device such as a syringe. It is used as an information transmission means to be transmitted to.
A×A′サイズのラベルで説明する。B×A′サイズの本体部13の表層4表面は、画線層3の中にE×A′サイズの捺印部15を備え、裏面に粘着層5を持つ。捺印部は容器内の薬液量等の管理に使用する。C×A′サイズの情報伝達部17表面は、本体部から続く画線層3の端にG×A′サイズの記名部18を備え、裏面に本体部から続く延べA×A′サイズの粘着層5を持つ。記名部は処方に基づき容器内の薬液を医療器具に移替える際、患者名・投薬量等を書入れミシン目13から切り離して注射器に貼る。 A description will be given with an A × A ′ size label. The surface of the surface layer 4 of the B × A ′ size main body portion 13 includes an E × A ′ size stamped portion 15 in the image line layer 3, and the adhesive layer 5 on the back surface. The marking part is used for managing the amount of chemicals in the container. The C × A ′ size information transmission portion 17 has a G × A ′ size name portion 18 at the end of the image layer 3 continuing from the main body portion, and a total A × A ′ size adhesive continuing from the main body portion on the back surface. It has layer 5. When transferring the drug solution in the container to the medical device based on the prescription, the registered part writes the patient name, dosage, etc. from the perforation 13 and puts it on the syringe.
表層4表面の画線層3上に厚み2〜2.5μmの範囲で不粘着性マスキング剤を塗布して保護層2を形成し、捺印部15と記名部18には塗布しない。表層裏面に粘着層5を形成した後、用途に合わせて転写用の網目を変え、範囲1〜1.5μmの厚みで不粘着性マスキング剤を塗布して調整層6を形成する。本体部13のJ×A′サイズ部分は20%の網点(粘着力80%)、情報伝達部17のK×A′サイズ部分に35%の網点(粘着力65%)とL×A′サイズ部分は網点なしで塗布(粘着力なし)した。 By applying a tack-masking agent in a range of thickness 2~2.5Myu m to form a protective layer 2 on the image line layer 3 of the surface layer 4 surface, not coated in register unit 18 and the seal site 15. After forming the adhesive layer 5 on the surface backside, changing the mesh to be transferred according to the application, to form the adjusting layer 6 by applying a tack-masking agent in a thickness ranging 1~1.5μ m. The J × A ′ size portion of the main body 13 is 20% halftone (adhesive strength 80%), and the K × A ′ size portion of the information transmitting portion 17 is 35% halftone (adhesive strength 65%) and L × A. 'The size portion was applied without a halftone dot (no adhesion).
ラベル1を使用するには剥離セパレート層7を外し、図5に示すバイアル20、図6に示すアンプル21に貼付ける。ラベル1の本体部13をバイアルの所要位置に貼るが、情報伝達部17の大部分は貼らないため、記名部18の両端19はバイアルやアンプル面に密着せずに開き気味となるので、転倒した時に開いた両端が転がり止めになる。本例の捺印部15と記名部18の位置は、本体部と情報伝達部の中の都合のよい位置を選べばよい。不粘着性マスキング剤には、光重合開始剤・アクリレートポリマー・多官能アクリレートモノマーを主成分とし、顔料・添加剤を加えたUV硬化型OPニスを使用した。 To use the label 1 Remove the peeling separation layer 7, the vial 20 illustrated in FIG. 5, pasted to the ampule 21 shown in FIG. Although the main body 13 of the label 1 is pasted at the required position of the vial, since most of the information transmission section 17 is not pasted, the both ends 19 of the marking section 18 are open without touching the vial or ampoule surface. The both ends that are opened when you do it will stop rolling. For the positions of the marking part 15 and the name part 18 in this example, a convenient position in the main body part and the information transmission part may be selected. As the non-adhesive masking agent, a UV curable OP varnish containing a photopolymerization initiator, an acrylate polymer, a polyfunctional acrylate monomer as a main component and a pigment and an additive added thereto was used.
1 ラベル
2 保護層
3 画線層(印刷)
4 表層(基材)
5 粘着層
6 調整層
7 剥離セパレート層
12 ミシン目
13 本体部
14 印刷部
15 捺印部
16 粘着部
17 情報伝達部
18 記名部
19 端
1 label
2 Protective layer 3 Image layer (printing)
4 Surface layer (base material)
5 Adhesive layer
6 Adjustment layer 7 Peeling separate layer 12 Perforation 13 Main body part 14 Printing part 15 Stamping part 16 Adhesion part 17 Information transmission part 18 Name part 19 End
Claims (2)
前記表層(4)表面には、印刷を施した画線層(3)と、記名部(18)・捺印部(15)を除く前記画線層(3)上に不粘着性マスキング剤を塗布した保護層(2)を設け、
前記表層(4)の背面には、粘着剤層(5)と、不粘着性マスキング剤を塗布した調整層(6)と、剥離セパレート層(7)とをその順に設け、
前記本体部(13)表面の不粘着性マスキング剤は厚み2〜2.5μmで網点がなく、前記本体部(13)背面の不粘着性マスキング剤は厚み1〜1.5μmで、範囲20〜50%から選択した網点として塗布し、
前記情報伝達部(17)表面の不粘着性マスキング剤は厚み2〜2.5μmで網点がなく、前記情報伝達部(17)の背面不粘着性マスキング剤は厚み1〜1.5μmで、網点なし又は範囲10〜30%から選択した網点を塗布した
ことを特徴とする誤用防止ラベル。 A label (1) of a required size having a surface layer (4) as a base material is divided into a main body (13) and an information transmission part (17), and the main body (13) and the information transmission part (17) In between, there is a tear perforation (12),
On the surface of the surface layer (4), a non-adhesive masking agent is applied on the image line layer (3) subjected to printing, and on the image line layer (3) excluding the marking part (18) and the stamp part (15). A protective layer (2)
The rear of the surface layer (4), and viscosity Chakuzaiso (5), adjustment layer coated tack masking agent (6), provided peeling separation layer (7) in this order,
The non-adhesive masking agent on the surface of the main body (13) has a thickness of 2 to 2.5 μm and no halftone dots, and the non-adhesive masking agent on the back of the main body (13) has a thickness of 1 to 1.5 μm and has a range of 20 Apply as a halftone dot selected from ~ 50%
The non-adhesive masking agent on the surface of the information transmission part (17) has a thickness of 2 to 2.5 μm and no halftone dots, and the back non-adhesive masking agent of the information transmission part (17) has a thickness of 1 to 1.5 μm. A misuse-preventing label, characterized in that it has no halftone dot or a halftone dot selected from a range of 10 to 30%.
The misuse prevention label according to claim 1, wherein the surface layer (4) as a base material is selected from a paper / synthetic resin film having a vapor deposition film or a paper / synthetic resin film not having a vapor deposition film and an aluminum foil.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003321901A JP4464646B2 (en) | 2003-09-12 | 2003-09-12 | Misuse prevention label |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003321901A JP4464646B2 (en) | 2003-09-12 | 2003-09-12 | Misuse prevention label |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005091506A JP2005091506A (en) | 2005-04-07 |
| JP4464646B2 true JP4464646B2 (en) | 2010-05-19 |
Family
ID=34453437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003321901A Expired - Lifetime JP4464646B2 (en) | 2003-09-12 | 2003-09-12 | Misuse prevention label |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4464646B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008033115A (en) * | 2006-07-31 | 2008-02-14 | Nipro Corp | label |
-
2003
- 2003-09-12 JP JP2003321901A patent/JP4464646B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005091506A (en) | 2005-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU720510B2 (en) | A removably replaceable, readherable label | |
| WO1997020007A9 (en) | A removably replaceable, readherable label | |
| US20090194451A1 (en) | Packaging for Storing a Free-flowing, Paste-like or Powdery Substance and Method for Storing and Applying the Substance | |
| JPS58216064A (en) | Flexible hermetically sealing cover comprising multiple layer, assembling thereof and re-sealing of inlet vein injection solution bag | |
| JP2002006743A (en) | Multi-layer label for drug management | |
| MXPA96005252A (en) | Packing of ampoules with backing of security for pildo | |
| JP2023014096A (en) | Multi-chamber container with labeled fluid | |
| JP4464646B2 (en) | Misuse prevention label | |
| US7514133B2 (en) | Label having transparent and opaque areas | |
| CN201685500U (en) | Medical infusion bottle hook label capable of being printed through thermal transfer | |
| JP2003108002A (en) | Multi-layer label for drug management | |
| JP3127448U (en) | Composite label for packaging container and cylindrical packaging container with the same | |
| JP5378699B2 (en) | Drug label | |
| JP2024172071A (en) | Medical labels and methods for attaching medical labels | |
| JP6119247B2 (en) | Container with adhesive label | |
| JP3151078U (en) | Label for packaging container and cylindrical packaging container with the label | |
| JP2002126041A (en) | Multi-layer label for drug management | |
| JP2006151467A (en) | Bag | |
| JP2002284180A (en) | Medicine bag with label | |
| KR101253592B1 (en) | Label sticker for syringes and the method thereof | |
| JP4837190B2 (en) | Drug container | |
| JP7154840B2 (en) | PTP sheet package | |
| JP3727195B2 (en) | Confidential information concealment label | |
| KR100843286B1 (en) | Syringe with label sheet | |
| JP3127034U (en) | Labeled medicine bag |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060322 |
|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20080730 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20081002 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090811 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091009 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091110 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091201 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100128 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100219 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130226 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4464646 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130226 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |